A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2009
10/29/2009	WO2009130344A1 Personalised pharmaceutical composition containing retinoic acid, for anti-aging of the skin
10/29/2009	WO2009130326A1 Combination therapy for acne vulgaris comprising adapalene 0.3% gel with clindamycin/benzoyl peroxide gel
10/29/2009	WO2009129627A1 Novel resveratrol compositions
10/29/2009	US20090270512 Pan-Antagonists For The Androgen Receptor And Androgen Receptor Mutants Associated With Anti-Androgen Withdrawal
10/29/2009	US20090270462 2-sulfanyl-substituted imidazole derivatives and their use as cytokine inhibitors
10/29/2009	US20090270458 Method of treating of demyelinating diseases or conditions
10/29/2009	US20090270437 Use of Buprenorphine or N-Alkylated Derivatives Thereof for Wound Healing
10/29/2009	US20090270427 Purine derivatives
10/29/2009	US20090270396 Therapeutic compounds
10/29/2009	US20090270392 prostaglandin EP2 receptor agonists for treating baldness, glaucoma, post-surgical and post-laser trabeculectomy ocular hypertensive episodes, inflammatory bowel disease, and as presurgical adjuncts
10/29/2009	US20090270386 Therapeutic compounds
10/29/2009	US20090270385 useful in treating vision defects, inflammatory bowel disease, alopecia, the stimulation of hair growth and the stimulation of the conversion of vellus hair to terminal hair
10/29/2009	US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics
10/29/2009	US20090270346 Protective gel based on chitosan and oxidized polysaccharide
10/29/2009	US20090270330 Purified arabinogalactan-protein (agp) composition useful in the treatment psoriasis and other disorders
10/29/2009	US20090269840 Kinase insert domain-containing receptor (KDR) specific immunoglobulin for monitoring tumor angiogenesis
10/29/2009	US20090269418 Compositions and Methods for Inducing Hair Growth
10/29/2009	US20090269410 Inhibition of Neovascularization by Cerium Oxide Nanoparticles
10/29/2009	US20090269398 Compositions for the encapsulation of natural product extracts in oil medium in hard gelatin capsules and a method of encapsulation
10/29/2009	DE102008020939A1 Preparing an extract e.g. for the regeneration of muscle tension, muscle-nerves and skin damage and scars and for the acceleration of wound healing, comprises extracting a body material of immunologically immature slaughtered animals
10/29/2009	DE102008020797A1 Skin cream useful for e.g. treatment and/or prophylaxis of dry skin and/or skin damage in diabetic foot, comprises saccharide e.g. mannobiose, polysaccharide e.g. dextran, multivalent alcohol e.g. glycerol, urea, polycation and carrier
10/29/2009	DE10029404B4 Arzneiformulierung enthaltend Ciclosporin und deren Verwendung Pharmaceutical formulation containing cyclosporine and their use
10/29/2009	CA2722456A1 Substituted arylcyclopentenes as prostaglandin ep2 agonists
10/29/2009	CA2722403A1 Substituted arylcyclopentenes as therapeutic agents
10/29/2009	CA2722340A1 Small-molecule inhibitors of the androgen receptor
10/29/2009	CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009	CA2722041A1 Novel five-membered ring compound
10/29/2009	CA2722007A1 Five-membered ring compound
10/29/2009	CA2720479A1 Combination therapy for acne vulgaris comprising adapalene 0.3% gel with clindamycin/benzoyl peroxide gel
10/28/2009	EP2112140A1 Chinazolin derivatives, medicine containing these compounds, application thereof and method for their production
10/28/2009	EP2111866A1 Products for oral use of extracts of plants to base of boehmeria nipononivea
10/28/2009	EP2111860A1 Inflammation inhibitor comprising zinc salt of acylamino acid
10/28/2009	EP2111391A1 New unsaturated fatty amino-acid derivatives and use thereof in dermal cosmetology
10/28/2009	EP2111387A1 New method for preparing unsaturated fatty hydroxy-acids
10/28/2009	EP1548032B9 Kdr peptides and vaccines comprising the same
10/28/2009	EP1503800B1 Treatment and prevention of tissue damage associated with increased c-reactive protein production
10/28/2009	EP1501538B1 Use of alpha-s2 casein precursor-derived peptides
10/28/2009	EP1379504B1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/28/2009	EP1371640B1 Novel a-lipoic acid derivative and use thereof
10/28/2009	EP1282434B1 Method for cell adhesion and wound healing
10/28/2009	EP1272168B2 Small organic molecule regulators of cell proliferation
10/28/2009	EP1261315B2 Echinacea extract as anti-irritant and anti-aging booster in cosmetic compositions
10/28/2009	EP1181047B2 Composition comprising alkaline sphingomyelinase of bacterial origin for use as a dietetic preparation, food supplement or pharmaceutical product
10/28/2009	EP1150666B1 Gm-csf for the treatment of crohn's disease
10/28/2009	EP1128731B1 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof
10/28/2009	CN101568552A Collagen peptide composition and food or beverage containing the same
10/28/2009	CN101564529A Five-poisonous-creature Keyin capsule of traditional Chinese medicine for treating psoriasis
10/28/2009	CN101564510A Chinese medicament liniment for effectively treating fungal infection of hand
10/28/2009	CN101564499A Acne dispelling Chinese medicament tincture special for men
10/28/2009	CN101564482A Compound liniment for treating acne rosacea
10/28/2009	CN101564444A Chinese medicament for treating burn and scald
10/28/2009	CN101564440A Anti-aging preparation
10/28/2009	CN101564426A Medicament for external use for treating onychomycosis
10/28/2009	CN101564420A Chinese medicinal herb composition for treating skin disease
10/28/2009	CN101564404A Application of cordyceps sinensis polysaccharide in prepaing medicament for resisting skin photoaging
10/28/2009	CN100554268C Multicyclic compounds and the use as inhibitors of PARP, VEGFR2 and MLK3 enzymes
10/28/2009	CN100553654C Ointment for treating burn and scald and preparation method thereof
10/28/2009	CN100553651C Externally-applied ointment for treating soft tissue inflammation
10/27/2009	US7608638 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
10/27/2009	US7608634 Substituted pyrrolines as kinase inhibitors
10/27/2009	US7608633 1-(4-Octylphenoxy)-3-(pyrrol-1-yl)propan-2-one, for example; for preventing and treating diseases caused by an increased activity of this enzyme, such as inflammation, pain, fever, allergies, asthma, psoriasis and endotoxic shock
10/27/2009	US7608624 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1h)-one derivatives
10/27/2009	US7608577 Peptidyl ketones as inhibitors of DPIV
10/27/2009	US7608284 Active enamel matrix substance, such as an amelogenin, a processed amelogenin product, or a metabolite can be used in treating conditions in a mammal which present an imbalance in its native immune resposne to external or internal stimuli
10/27/2009	US7608269 Compositions and methods for treating cancer by modulating HER-2 and EGF receptors
10/27/2009	CA2477019C Use of total coumarins of cnidium fruit in preparing medicaments for treating psoriasis
10/27/2009	CA2473393C Semi-fluorinated alkanes and their use
10/27/2009	CA2466724C Benzamide and heteroarylamide as p2x7 receptor antagonists
10/27/2009	CA2432713C Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
10/27/2009	CA2381885C Isomeric fused pyrrolocarbazoles and isoindolones
10/27/2009	CA2376355C N-heterocyclic derivatives as nos inhibitors
10/27/2009	CA2365204C Lipoxin compounds and their use
10/27/2009	CA2338141C Polymer complexes of glucuronoglucanes
10/25/2009	CA2629979A1 Novel resveratrol compositions
10/22/2009	WO2009129336A2 Penetrating carrier, antifungal composition using the same and method for treatment of dermatophyte infections
10/22/2009	WO2009128558A1 Activator for peroxisome proliferator-activated receptor
10/22/2009	WO2009128520A1 Heterocyclic compound having inhibitory activity on p13k
10/22/2009	WO2009128474A1 Method of producing thrombin-immobilized bioabsorbable sheet preparation
10/22/2009	WO2009128076A2 Methods of generating and using procollagen
10/22/2009	WO2009127869A2 New Use
10/22/2009	WO2009106715A3 Peptide derived from a protein of the aquaporin family
10/22/2009	WO2009063493A3 Topical pharmaceutical composition for the combination of fusidic acid and a corticosteroid
10/22/2009	WO2009027382A3 Sprayable composition containing red vine leaf extract
10/22/2009	WO2008020329A3 Administration of cells and cellular extracts for rejuvenation
10/22/2009	US20090265798 Desaturase genes and uses thereof
10/22/2009	US20090264624 Human cytokine receptor
10/22/2009	US20090264541 Cosmetic composition comprising an oil
10/22/2009	US20090264527 Method for stabilizing retinoic acid, retinoic acid containing composition, and method of using a retinoic acid containing composition
10/22/2009	US20090264517 Milbemycin compounds and treatment of dermatological disorders in humans therewith
10/22/2009	US20090264516 Milbemycin compounds and treatment of dermatological disorders in humans therewith
10/22/2009	US20090264501 Methods and Compositions to Inhibit P2x7 Receptor Expression
10/22/2009	US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009	US20090264415 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment
10/22/2009	US20090264396 17Alpha, 21-Dihydroxypregnene esters as antiandrogenic agents
10/22/2009	US20090264394 Nitrooxy derivatives of glucocorticoids
10/22/2009	US20090264384 Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
10/22/2009	US20090264378 Avermectin compounds and treatment of dermatological disorders in humans therewith
10/22/2009	US20090264370 Polypeptides homologous to vegf and bmp1
10/22/2009	US20090264364 Genes implicated in the regulation of angiogenesis, pharmaceutical preparations containing them and their applications
10/22/2009	US20090264345 Macrocyclic peptides and methods for making and using them

1 ... 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 ... 1065